Novo Nordisk (NVO -2.38%) has sparked investor interest primarily because of its weight loss treatments.
*Stock prices used were the afternoon prices of Jan. 2, 2025. The video was published on Jan. 4, 2025.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Is Novo Nordisk an Undervalued Stock to Buy Now?
By Parkev Tatevosian, CFA
–
Jan 4, 2025 at 7:29PM
NYSE: NVO
Novo Nordisk
Market Cap
$284B
Today's Change
(-2.38%) -$2.02
Current Price
$83.00
Price as of January 7, 2025, 2:26 p.m. ET
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.